CoQ10, Melatonin and NAC for Oocyte Quality: What the Evidence Actually Says
Key Takeaways
CoQ10, melatonin and N-acetylcysteine are widely marketed as "egg quality" supplements before IVF. While small trials show minor signals on lab markers such as mature oocyte count or embryo grading, no clear live-birth benefit has been established. ESHRE’s 2023 add-ons guidance evaluates oral antioxidants as a broad class and does not recommend them routinely in ART. In diminished ovarian reserve or prior poor response, CoQ10 may be discussed with strict boundaries on evidence, expense, and duration. Supplements should never postpone active fertility treatment.
Key evidence: Xu et al. — CoQ10 pretreatment RCT in diminished ovarian reserve (2018) ESHRE — Good practice recommendations on add-ons in reproductive medicine (2023) Showell et al. — Cochrane review: antioxidants for female subfertility (2020)
Before an IVF cycle, especially after a failed attempt or a diagnosis of low ovarian reserve, it is natural to want to do everything you can. That is why supplements such as CoQ10, melatonin and N-acetylcysteine (NAC) come up so often on patient forums and social media.
The evidence draws a clear line. These molecules have a plausible biological rationale, and some trials show small changes in laboratory measures. None has been shown to increase live-birth rates in rigorous trials.
ESHRE’s 2023 good-practice recommendations on add-ons assessed oral antioxidants as one broad category rather than product by product, and concluded that routine antioxidant therapy is not recommended in ART. Knowing this can protect both your budget and your treatment timeline.
The video below is in French.
What “oocyte quality” actually means
“Oocyte quality” is often talked about as if it were a single score out of ten. In fact it covers three different things, each driven by its own biology:
1. Maturity: Only an egg that has reached metaphase II (MII) can be fertilized. An immature egg at collection cannot be fertilized, and no supplement taken days or weeks earlier can change that on the day.
2. Chromosomes: With age, especially from the late thirties, errors in the egg’s cell-division machinery become more common. More eggs then carry the wrong number of chromosomes (aneuploidy). No supplement or antioxidant has been shown to reverse this. It is biology, not a failure of diet or self-care.
3. Energy: Each egg contains hundreds of thousands of mitochondria. They supply the energy (ATP) needed for fertilization and the first cell divisions.
Some studies report small changes in egg numbers or embryo grades. No supplement has been shown to repair chromosome errors or to reliably improve the outcome that matters: a healthy live birth.
Coenzyme Q10
Coenzyme Q10 (ubiquinone, or its reduced form ubiquinol) is a key cofactor in the mitochondrial energy chain. Mitochondrial efficiency may fall with reproductive age. The idea is simple: top up the cofactor, and an older egg might produce more usable energy as it matures.
The most-cited trial is Xu et al. (2018). It randomized young women (under 35) with low ovarian reserve, not women over 40. Women who took CoQ10 (600 mg a day for 60 days before stimulation) had more eggs collected and more good-quality day-3 embryos, which was the trial’s main outcome. Fewer of them ended the cycle without an embryo transfer.
Live birth, the outcome that matters most, was only a secondary measure. Cumulative live births were 28.95% with CoQ10 and 15.54% without it. The authors reported that this difference was not statistically significant, and the trial was not sized to test it. There are other limits too. The trial had no placebo and both women and doctors knew who took CoQ10. Also, 17 of the 93 women assigned to CoQ10 were left out of the analysis, mostly because they stopped taking it. So the trial did not establish a live-birth benefit, and the wider antioxidant evidence is too uncertain to confirm one.
This is the central problem with fertility-supplement research. Lab markers can move without more babies being born. A slightly better embryo grade is a signal, not proof of a pregnancy.
In practice, CoQ10 has plausible biology and is usually well tolerated in the short term. But product quality varies between brands, interactions can occur, and any supplement should be reviewed with your fertility team. It does not cure age-related aneuploidy and it is not a licensed fertility drug. Results from young women with low reserve may not apply to older women.
Melatonin
Melatonin drew interest because it is a strong antioxidant in the fluid around the egg. An early small study by Tamura et al. (2008) gave 3 mg a day to women whose previous IVF cycle had a low fertilization rate. Their fertilization rate improved compared with that earlier cycle. The study was small and not described as randomized, so it is a preliminary signal, not proof.
Later studies were mixed. They used 3 to 6 mg a day, for two weeks to three months, in very different groups of women. Meta-analyses point in different directions depending on which studies they pool. As with CoQ10, better lab results have not reliably turned into more live births. The Cochrane systematic review on female antioxidants concluded that evidence for a live-birth benefit across antioxidant strategies remains of low to very low certainty.
Melatonin is also a hormone, not a neutral food supplement. Daytime drowsiness, changes in sleep and interactions with other medicines are real effects. Do not start it without talking to your fertility doctor, especially when you are trying to conceive.
ESHRE evaluates oral antioxidants collectively and does not recommend antioxidant therapy routinely in ART; this reflects the overall evidence base rather than a product-specific endorsement or rejection of melatonin.
N-acetylcysteine (NAC)
N-acetylcysteine (NAC) is a building block of glutathione, the cell’s main antioxidant. It may also improve insulin sensitivity. That is why it was mostly studied in polycystic ovary syndrome (PCOS), not as a general egg-quality supplement.
In PCOS, small and varied trials have compared NAC with metformin, with mixed results. The 2023 International Evidence-Based PCOS Guideline bases ovulation induction on established treatments such as letrozole and metformin, not NAC.
Outside PCOS, claims about “NAC for egg quality” are extrapolation. There is no agreed dose, no agreed duration, no convincing randomized trial showing more live births, and no endorsement from an international fertility society.
Where ESHRE has stood since 2023
ESHRE’s 2023 good-practice recommendations on add-ons assessed oral antioxidants as one category rather than rating CoQ10, melatonin or NAC one by one. Trials have not confirmed a clear live-birth benefit, so routine antioxidant supplements are not recommended in ART.
For patients, that is the key point: the live-birth benefit is uncertain and there is no routine recommendation. No guideline committee has examined individual brands or given them a stamp of approval.
Who, in practice, might still consider these?
Three situations come up most often in consultation:
Diminished ovarian reserve or previous poor response
I do not recommend CoQ10 routinely. When a woman with low ovarian reserve or a previous poor response asks about it, we talk about the limited evidence, the cost, possible side effects, and the fact that a live-birth benefit has not been shown. This conversation should never delay the start of treatment.
A common worry is that starting stimulation before three months of CoQ10 “wastes” it. It does not. Some studies show better egg and embryo results, but postponing stimulation to finish three months of CoQ10 has not been shown to raise the chance of a live birth. So I do not postpone a cycle planned for two or three weeks’ time just because the supplement course is not finished.
I look first at age, then at how many mature eggs the last stimulation produced and how the embryos developed. AMH and antral follicle count help me plan the expected response, but on their own they are not a reason to wait. From 38 onwards, or after a very poor previous response, I would not spend time on CoQ10. In a younger woman, we may agree to skip one cycle if there is already a reason to rethink the last protocol, but not in the belief that three months of CoQ10 will secure success.
Trials have used different products and schedules, commonly 200–600 mg a day for about one to three months before stimulation. These are study regimens, not a proven prescription. Review any supplement with your clinic: product quality varies, interactions are possible, and the clinic can tell you when to stop.
Unregulated herbal products sold for fertility add further risks: uncertain contents, interactions, and concerns around the time of egg collection. If the ovarian reserve is severely compromised, the most critical conversation is about cycle logistics, protocol adjustments, or considering legally available alternatives in the appropriate jurisdiction — never about accumulating more bottles of supplements.
The young patient with normal reserve
In a younger woman with normal ovarian reserve, age-related loss of egg energy is rarely the limiting factor. Spending large sums on premium supplements before a first or second IVF attempt is seldom money well spent. Sleep, good food and emotional support help well-being during treatment. They should not be sold as ways to raise live-birth rates.
The patient with PCOS
NAC has been studied in PCOS, but the evidence is too heterogeneous to position it as a standard alternative to metformin or as an egg-quality drug. The 2023 international PCOS guideline does not include NAC among recommended fertility therapies. Metabolic care and ovulation induction remain centred on established options such as letrozole and metformin.
Foundations that still matter
Single supplements rarely change fertility outcomes. These basics do support general and preconception health:
- Folic acid: Recommended before conception, at the right dose, to lower the risk of neural-tube defects. It protects the baby; it is not a way to raise IVF success rates.
- Deficiencies: Correcting deficiencies confirmed by blood tests, such as vitamin D or iron.
- Stopping smoking: Tobacco and nicotine harm the follicles and blood vessels.
- Balanced diet: A varied, Mediterranean-style diet rich in whole foods and healthy fats.
- Activity and sleep: Regular moderate exercise and enough sleep.
- Alcohol: Avoiding alcohol while trying to conceive.
None of these looks exciting on a pharmacy shelf, which is why they are often undervalued. They should be neither ignored nor oversold.
Related Reading
- DHEA and Growth Hormone in IVF: What the Evidence Says
- How Many Eggs Are Usually Enough for IVF?
- IVF Failure: Common Causes and What They Mean for Next Steps
- Male Fertility Supplements: What They May Help and What They Cannot Fix
FAQ
Does CoQ10 actually “rejuvenate” eggs?
No. CoQ10 may modestly support energy production in laboratory models. It does not repair the chromosome errors (aneuploidy) behind age-related infertility. No treatment or supplement has been shown to do that.
Is it safe to combine CoQ10, melatonin and NAC before IVF?
They are usually tolerated over short periods, but safety is not guaranteed. Three supplements do not add up to three benefits. No good-quality trial has tested this combination for live birth, and side effects (stomach upset, daytime tiredness, disturbed sleep) become more likely. Review any combination with your fertility doctor, especially when you are trying to conceive.
What dose of CoQ10 was used in clinical trials?
Trials have commonly used 200 to 600 mg a day of ubiquinone or ubiquinol, for one to three months before stimulation. The Xu trial used 600 mg a day for 60 days. These are research regimens, not a proven prescription.
How long before IVF should you start, if at all?
The theory assumes the supplement is present while the follicles make their final growth, which takes about two to three months before egg collection. Starting one week before stimulation is largely symbolic. Even so, a planned cycle should not be postponed just to complete the course. Decide the timing, including when to stop, with your clinic.
Are these supplements covered by IVF clinics?
Usually not; you pay for them yourself. Weigh that cost against other parts of your care, and do not assume any supplement will raise live-birth rates on its own.
When should you be sceptical of an “egg quality” claim?
Be cautious when a product promises a number of “years younger”, cites vague “studies” without full references, treats lab markers as if they were live births, or is sold to you in the same consultation that plans your treatment.
Clinical note
What concerns me is not that a patient asks about CoQ10. It is when several branded supplements are sold as though they can reverse reproductive ageing or compensate for a poor prognosis. I explain that the laboratory signals are preliminary, a live-birth benefit has not been established, and no supplement should delay a treatment decision driven by age, ovarian reserve or previous response.
Dr. Senai Aksoy
Sources
- Xu Y, Nisenblat V, Lu C, et al. “Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial.” Reproductive Biology and Endocrinology. 2018;16(1):29. PubMed
- Tamura H, Takasaki A, Miwa I, et al. “Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate.” Journal of Pineal Research. 2008;44(3):280-287. PubMed
- Showell MG, Mackenzie-Proctor R, Jordan V, Hart RJ. “Antioxidants for female subfertility.” Cochrane Database of Systematic Reviews. 2020;8:CD007807. Cochrane Library
- ESHRE Add-ons Working Group. “Good practice recommendations on add-ons in reproductive medicine.” Human Reproduction. 2023;38(11):2062-2104. ESHRE
- Teede HJ, Tay CT, Laven JJE, et al. “Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.” Fertility and Sterility. 2023;120(4):767-793. PubMed
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.